Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Bladder Cancer

  Free Subscription


Articles published in Curr Opin Urol

Retrieve available abstracts of 67 articles:
HTML format



Single Articles


    July 2021

  1. Bladder-preserving strategies for Bacillus Calmette-Guerin unresponsive non-muscle invasive bladder cancer; where are we and what will be expected?: Erratum.
    Curr Opin Urol. 2021;31:436.
    PubMed    


    June 2021
  2. JANSSEN GWB, Ramkumar RR, Lee BH, van der Heijden AG, et al
    Orthotopic urinary diversions after radical cystectomy for bladder cancer: lessons learned last decade.
    Curr Opin Urol. 2021 Jun 25. pii: 00042307-900000000-98856.
    PubMed     Abstract available


    May 2021
  3. CHAN EO, Pradere B, Teoh JY
    The use of artificial intelligence for the diagnosis of bladder cancer: a review and perspectives.
    Curr Opin Urol. 2021 May 11. pii: 00042307-900000000-98866.
    PubMed     Abstract available


  4. ZIMMERMANN K, Mostafaei H, Heidenreich A, Schmelz HU, et al
    Health-related quality of life in bladder cancer patients: bladder cancer-specific instruments and domains. Part 2.
    Curr Opin Urol. 2021 May 10. pii: 00042307-900000000-98868.
    PubMed     Abstract available


  5. SCHUETTFORT VM, Pradere B, Comperat E, Abufaraj M, et al
    Novel transurethral resection technologies and training modalities in the management of nonmuscle invasive bladder cancer: a comprehensive review.
    Curr Opin Urol. 2021 May 10. pii: 00042307-900000000-98867.
    PubMed     Abstract available


  6. ZIMMERMANN K, Mostafaei H, Heidenreich A, Schmelz HU, et al
    Part I. Health-related quality of life in bladder cancer patients: general and cancer-specific instruments.
    Curr Opin Urol. 2021 May 6. pii: 00042307-900000000-98874.
    PubMed     Abstract available


  7. PACKIAM VT, Richards J, Schmautz M, Heidenreich A, et al
    The current landscape of salvage therapies for patients with bacillus Calmette-Guerin unresponsive nonmuscle invasive bladder cancer.
    Curr Opin Urol. 2021;31:178-187.
    PubMed     Abstract available


  8. ABUFARAJ M, Al-Ani A, AlQudah A, Shariat SF, et al
    Surgical intervention in patients with urothelial carcinoma of the bladder and lymph node metastasis.
    Curr Opin Urol. 2021;31:220-225.
    PubMed     Abstract available


    April 2021
  9. PINAR U, Pradere B, Roupret M
    Artificial intelligence in bladder cancer prognosis: a pathway for personalized medicine.
    Curr Opin Urol. 2021 Apr 20. pii: 00042307-900000000-98882.
    PubMed     Abstract available


    December 2020
  10. HUGAR LA, Gilbert SM, Sexton WJ, Kamat AM, et al
    Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancer.
    Curr Opin Urol. 2020;Publish Ahead of Print.
    PubMed     Abstract available


    September 2020

  11. Bladder-preserving strategies for Bacillus Calmette-Guerin unresponsive non-muscle invasive bladder cancer; where are we and what will be expected?: Erratum.
    Curr Opin Urol. 2020;30:746.
    PubMed    


  12. SARI MOTLAGH R, Mori K, Aydh A, Karakiewicz PI, et al
    Impact of hospital and surgeon volumes on short-term and long-term outcomes of radical cystectomy.
    Curr Opin Urol. 2020;30:701-710.
    PubMed     Abstract available


  13. REBHAN K, Ertl IE, Shariat SF, Grollman AP, et al
    Aristolochic acid and its effect on different cancers in uro-oncology.
    Curr Opin Urol. 2020;30:689-695.
    PubMed     Abstract available


    July 2020
  14. MORI K, Mostafaei H, Abufaraj M, Yang L, et al
    Smoking and bladder cancer: review of the recent literature.
    Curr Opin Urol. 2020 Jul 20. doi: 10.1097/MOU.0000000000000804.
    PubMed     Abstract available


  15. EINERHAND SMH, van Gennep EJ, Mertens LS, Hendricksen K, et al
    18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer.
    Curr Opin Urol. 2020 Jul 20. doi: 10.1097/MOU.0000000000000798.
    PubMed     Abstract available


  16. GUST KM, Rebhan K, Resch I, Shariat SF, et al
    Immune checkpoint inhibition in muscle-invasive and locally advanced bladder cancer.
    Curr Opin Urol. 2020;30:547-556.
    PubMed     Abstract available


  17. ERTL IE, Shariat SF, Mostafaei H, Ilijazi D, et al
    Fibroblast growth factor receptors across urothelial carcinoma landscape.
    Curr Opin Urol. 2020;30:557-565.
    PubMed     Abstract available


  18. BRONIMANN S, Lemberger U, Bruchbacher A, Shariat SF, et al
    Poly(ADP-ribose) polymerase inhibitors in prostate and urothelial cancer.
    Curr Opin Urol. 2020;30:519-526.
    PubMed     Abstract available


  19. LIU B, Welk B
    Urological malignancies in neurogenic patients.
    Curr Opin Urol. 2020;30:501-506.
    PubMed     Abstract available


    May 2020
  20. SORIA F, Giordano A, Shariat SF, Gontero P, et al
    Bladder sparing landscape for bacillus Calmette-Guerin unresponsive bladder cancer.
    Curr Opin Urol. 2020 May 13. doi: 10.1097/MOU.0000000000000789.
    PubMed     Abstract available


  21. PRADERE B, Schuettfort V, Mori K, Quhal F, et al
    Management of de-novo urothelial carcinoma in transplanted patients.
    Curr Opin Urol. 2020;30:467-474.
    PubMed     Abstract available


  22. JAHRREISS V, Pradere B, Laukhtina E, Mori K, et al
    Catalog of exogenous risk factors for bladder carcinogenesis.
    Curr Opin Urol. 2020;30:449-456.
    PubMed     Abstract available


  23. CARANDO R, Shariat SF, Moschini M, D'Andrea D, et al
    Ureteral and urethral recurrence after radical cystectomy: a systematic review.
    Curr Opin Urol. 2020;30:441-448.
    PubMed     Abstract available


  24. KHETRAPAL P, Conroy S, Kelly JD, Catto JWF, et al
    Comparing open-radical cystectomy and robot-assisted radical cystectomy: current status and analysis of the evidence.
    Curr Opin Urol. 2020;30:400-406.
    PubMed     Abstract available


  25. SUBIELA JD, Rodriguez Faba O, Guerrero-Ramos F, Aumatell J, et al
    Carcinoma in situ of the bladder: why is it underdetected?
    Curr Opin Urol. 2020;30:392-399.
    PubMed     Abstract available


  26. SORIA F, Giordano A, Gontero P
    Transurethral resection of bladder tumor and the need for re-transurethral resection of bladder tumor: time to change our practice?
    Curr Opin Urol. 2020;30:370-376.
    PubMed     Abstract available


  27. TERRITO A, Bevilacqua G, Meneghetti I, Mercade A, et al
    En bloc resection of bladder tumors: indications, techniques, and future directions.
    Curr Opin Urol. 2020;30:421-427.
    PubMed     Abstract available


  28. LOTAN Y
    Novel technologies that change the diagnostic and treatment paradigm in urology: standard turbt remains the standard.
    Curr Opin Urol. 2020;30:477-478.
    PubMed    


  29. ALMASSI N, Bochner BH
    Ileal conduit or orthotopic neobladder: selection and contemporary patterns of use.
    Curr Opin Urol. 2020;30:415-420.
    PubMed     Abstract available


    April 2020
  30. SARI MOTLAGH R, Pradere B, Mori K, Miura N, et al
    Bladder-preserving strategies for Bacillus Calmette-Guerin unresponsive non-muscle invasive bladder cancer; where are we and what will be expected?
    Curr Opin Urol. 2020 Apr 16. doi: 10.1097/MOU.0000000000000769.
    PubMed     Abstract available


    March 2020
  31. FABA OR, Palou J
    Emerging approaches and future perspectives in nonmuscle invasive bladder cancer.
    Curr Opin Urol. 2020 Mar 19. doi: 10.1097/MOU.0000000000000766.
    PubMed    


  32. SUNG HH, Lerner SP
    Utility of lymphadenectomy in bladder cancer: where do we stand?
    Curr Opin Urol. 2020 Mar 19. doi: 10.1097/MOU.0000000000000750.
    PubMed     Abstract available


  33. CIPOLLARI S, Carnicelli G, Bicchetti M, Campa R, et al
    Utilization of imaging for staging in bladder cancer: is there a role for MRI or PET-computed tomography?
    Curr Opin Urol. 2020 Mar 9. doi: 10.1097/MOU.0000000000000743.
    PubMed     Abstract available


  34. LENFANT L, Aminsharifi A, Seisen T, Roupret M, et al
    Current status and future directions of the use of novel immunotherapeutic agents in bladder cancer.
    Curr Opin Urol. 2020 Mar 5. doi: 10.1097/MOU.0000000000000740.
    PubMed     Abstract available



  35. Bacillus Calmette-Guerin (BCG) treatment of bladder cancer: a systematic review and commentary on recent publications: Erratum.
    Curr Opin Urol. 2020;30:281.
    PubMed    


    February 2020
  36. FANKHAUSER CD, Teoh JY, Mostafid H
    Treatment options and results of adjuvant treatment in nonmuscle-invasive bladder cancer (NMIBC) during the Bacillus Calmette-Guerin shortage.
    Curr Opin Urol. 2020 Feb 25. doi: 10.1097/MOU.0000000000000739.
    PubMed     Abstract available


  37. WITJES JA
    Developments in the follow-up of nonmuscle invasive bladder cancer: what did we learn the last 24 months: a critical review.
    Curr Opin Urol. 2020 Feb 25. doi: 10.1097/MOU.0000000000000741.
    PubMed     Abstract available


    November 2019
  38. MORI K, D'Andrea D, Enikeev DV, Egawa S, et al
    En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature.
    Curr Opin Urol. 2019 Nov 12. doi: 10.1097/MOU.0000000000000697.
    PubMed     Abstract available


    July 2019
  39. SADIGHIAN M, Porten S
    Gender differences in oncologic and functional outcomes in patients with bladder cancer undergoing radical cystectomy with urinary diversion.
    Curr Opin Urol. 2019 Jul 15. doi: 10.1097/MOU.0000000000000660.
    PubMed     Abstract available


  40. SATYAL U, Sikder RK, McConkey D, Plimack ER, et al
    Clinical implications of molecular subtyping in bladder cancer.
    Curr Opin Urol. 2019;29:350-356.
    PubMed     Abstract available


    May 2019
  41. POZO C, Shariat SF, D'Andrea D, Fajkovic H, et al
    Enhanced Recovery after Radical Cystectomy.
    Curr Opin Urol. 2019;29:227-238.
    PubMed     Abstract available


  42. BURG ML, Daneshmand S
    Frailty and preoperative risk assessment before radical cystectomy.
    Curr Opin Urol. 2019;29:216-219.
    PubMed     Abstract available


  43. HASSLER MR, Shariat SF, Soria F
    Salvage therapeutic strategies for bacillus Calmette-Guerin failure.
    Curr Opin Urol. 2019;29:239-246.
    PubMed     Abstract available


  44. CACCIAMANI GE, Rajarubendra N, Artibani W, Gill IS, et al
    Robotic intracorporeal urinary diversion: state of the art.
    Curr Opin Urol. 2019;29:293-300.
    PubMed     Abstract available


    March 2019
  45. JANISCH F, Shariat SF, Schernhammer E, Rink M, et al
    The interaction of gender and smoking on bladder cancer risks.
    Curr Opin Urol. 2019 Mar 14. doi: 10.1097/MOU.0000000000000602.
    PubMed     Abstract available


  46. MUN DH, Kimura S, Shariat SF, Abufaraj M, et al
    The impact of gender on oncologic outcomes of bladder cancer.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000606.
    PubMed     Abstract available


  47. EULITT PJ, Bjurlin MA, Milowsky MI
    Perioperative systemic therapy for bladder cancer.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000600.
    PubMed     Abstract available


  48. SMELSER WW, Woolbright BL, Taylor JA 3rd
    Molecular subtyping of bladder cancer: current trends and future directions in 2019.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000599.
    PubMed     Abstract available


  49. PHAM A, Ballas LK
    Trimodality therapy for bladder cancer: modern management and future directions.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000601.
    PubMed     Abstract available


  50. BHAT A, Ritch CR
    Urinary biomarkers in bladder cancer: where do we stand?
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000605.
    PubMed     Abstract available


    February 2019
  51. NASER-TAVAKOLIAN A, Ghodoussipour S, Djaladat H
    Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management.
    Curr Opin Urol. 2019 Feb 11. doi: 10.1097/MOU.0000000000000598.
    PubMed     Abstract available


  52. MUKHERJEE N, Wheeler KM, Svatek RS
    Bacillus Calmette-Guerin treatment of bladder cancer: a systematic review and commentary on recent publications.
    Curr Opin Urol. 2019 Feb 11. doi: 10.1097/MOU.0000000000000595.
    PubMed     Abstract available


    January 2019
  53. BANDINI M, Fossati N, Briganti A
    Nomograms in urologic oncology, advantages and disadvantages.
    Curr Opin Urol. 2019;29:42-51.
    PubMed     Abstract available


    September 2018
  54. BRUCHBACHER A, Soria F, Hassler M, Shariat SF, et al
    Tissue biomarkers in nonmuscle-invasive bladder cancer: any role in clinical practice?
    Curr Opin Urol. 2018 Sep 3. doi: 10.1097/MOU.0000000000000546.
    PubMed     Abstract available


    August 2018
  55. SORIA F, D'Andrea D, Pohar K, Shariat SF, et al
    Diagnostic, prognostic and surveillance urinary markers in nonmuscle invasive bladder cancer: any role in clinical practice?
    Curr Opin Urol. 2018 Aug 27. doi: 10.1097/MOU.0000000000000545.
    PubMed     Abstract available


  56. MANNAS MP, Lee T, Nykopp TK, Costa JBD, et al
    A risk-stratified approach to the management of high-grade T1 bladder cancer.
    Curr Opin Urol. 2018 Aug 24. doi: 10.1097/MOU.0000000000000548.
    PubMed     Abstract available


  57. DYRSKJOT L, Ingersoll MA
    Biology of nonmuscle-invasive bladder cancer: pathology, genomic implications, and immunology.
    Curr Opin Urol. 2018 Aug 21. doi: 10.1097/MOU.0000000000000543.
    PubMed     Abstract available


  58. SCHRAML J, Silva JDC, Babjuk M
    Current concept of transurethral resection of bladder cancer: from re-transurethral resection of bladder cancer to en-bloc resection.
    Curr Opin Urol. 2018 Aug 9. doi: 10.1097/MOU.0000000000000542.
    PubMed     Abstract available


    March 2018
  59. DASON S, Goh AC
    Contemporary techniques and outcomes of robotic cystectomy and intracorporeal urinary diversions.
    Curr Opin Urol. 2018;28:115-122.
    PubMed     Abstract available


    January 2018
  60. FANKHAUSER CD, Mostafid H
    Prevention of bladder cancer incidence and recurrence: nutrition and lifestyle.
    Curr Opin Urol. 2018;28:88-92.
    PubMed     Abstract available


    October 2017
  61. MARI A, Abufaraj M, Gust KM, Shariat SF, et al
    Novel endoscopic visualization techniques for bladder cancer detection: a review of the contemporary literature.
    Curr Opin Urol. 2017 Oct 17. doi: 10.1097/MOU.0000000000000459.
    PubMed     Abstract available


  62. SORIA F, Marra G, Capoun O, Soukup V, et al
    Prevention of bladder cancer incidence and recurrence: tobacco use.
    Curr Opin Urol. 2017 Oct 3. doi: 10.1097/MOU.0000000000000453.
    PubMed     Abstract available


    June 2017
  63. GILD P, Ehdaie B, Kluth LA
    Effect of obesity on bladder cancer and renal cell carcinoma incidence and survival.
    Curr Opin Urol. 2017 Jun 24. doi: 10.1097/MOU.0000000000000425.
    PubMed     Abstract available


    December 2016
  64. HERRMANN TR, Wolters M, Kramer MW
    Transurethral en bloc resection of nonmuscle invasive bladder cancer: trend or hype.
    Curr Opin Urol. 2016 Dec 28. doi: 10.1097/MOU.0000000000000377.
    PubMed     Abstract available


  65. LIEM EI, de Reijke TM
    Can we improve transurethral resection of the bladder tumour for nonmuscle invasive bladder cancer?
    Curr Opin Urol. 2016.
    PubMed     Abstract available


    May 2016
  66. SELTZ LM, Herrell SD
    Applications of spectroscopy in diagnosis, staging, and treatment of urologic malignancies.
    Curr Opin Urol. 2016;26:259-63.
    PubMed     Abstract available


    January 2016
  67. CHOPRA S, Abreu AL, Gill IS
    Robotic urinary diversion: the range of options.
    Curr Opin Urol. 2016;26:107-13.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: